Drug-resistant TB responds rapidly to bedaquiline-based therapy
February 28, 2024
February 28, 2024
ITHACA, New York, Feb. 28 -- Cornell University issued the following news:
Patients who have drug-resistant tuberculosis (TB) have a similar microbiological response to bedaquiline-based second-line medications as patients with drug-sensitive TB taking first-line regimens, according to researchers at Weill Cornell Medicine and GHESKIO Centers in Haiti.
Second-line medications are those that are given when one or more of the drugs given first for the disease are not effe . . .
Patients who have drug-resistant tuberculosis (TB) have a similar microbiological response to bedaquiline-based second-line medications as patients with drug-sensitive TB taking first-line regimens, according to researchers at Weill Cornell Medicine and GHESKIO Centers in Haiti.
Second-line medications are those that are given when one or more of the drugs given first for the disease are not effe . . .